PL366240A1 - Sposób indukowania reakcji przeciwnowotworowej przeciwko przerzutom płucnym u pacjentów z czerniakiem - Google Patents

Sposób indukowania reakcji przeciwnowotworowej przeciwko przerzutom płucnym u pacjentów z czerniakiem

Info

Publication number
PL366240A1
PL366240A1 PL99366240A PL36624099A PL366240A1 PL 366240 A1 PL366240 A1 PL 366240A1 PL 99366240 A PL99366240 A PL 99366240A PL 36624099 A PL36624099 A PL 36624099A PL 366240 A1 PL366240 A1 PL 366240A1
Authority
PL
Poland
Prior art keywords
inducing
response against
tumor response
lung metastasis
melanoma patient
Prior art date
Application number
PL99366240A
Other languages
English (en)
Inventor
David Berd
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Publication of PL366240A1 publication Critical patent/PL366240A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL99366240A 1998-04-09 1999-04-09 Sposób indukowania reakcji przeciwnowotworowej przeciwko przerzutom płucnym u pacjentów z czerniakiem PL366240A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8125698P 1998-04-09 1998-04-09

Publications (1)

Publication Number Publication Date
PL366240A1 true PL366240A1 (pl) 2005-01-24

Family

ID=22163059

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99366240A PL366240A1 (pl) 1998-04-09 1999-04-09 Sposób indukowania reakcji przeciwnowotworowej przeciwko przerzutom płucnym u pacjentów z czerniakiem

Country Status (8)

Country Link
EP (1) EP1067960A2 (pl)
JP (1) JP2003524583A (pl)
CN (1) CN1301174A (pl)
AR (1) AR020067A1 (pl)
AU (1) AU3482199A (pl)
CA (1) CA2327339A1 (pl)
PL (1) PL366240A1 (pl)
WO (1) WO1999052546A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000057911A2 (en) 1999-03-16 2000-10-05 Thomas Jefferson University Hapten-conjugated mammalian cells and methods of making and using thereof
JP2004507446A (ja) * 2000-02-04 2004-03-11 トーマス・ジェファーソン・ユニバーシティ 低用量ハプテン化腫瘍細胞および腫瘍細胞抽出物の免疫治療
US7297330B2 (en) 2000-02-04 2007-11-20 Thomas Jefferson University Low dose haptenized tumor cell and tumor cell extract immunotherapy
WO2003103389A2 (en) 2002-06-10 2003-12-18 Avax Technologies Inc. Cryopreservation of haptenized tumor cells
FR3011850B1 (fr) * 2013-10-15 2018-04-06 Cfl Biotech Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes
GB2630768B (en) * 2023-06-07 2025-07-02 Alv B As Administration of bacterial composition for use in treatment of lung metastases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2302337T3 (es) * 1995-06-07 2008-07-01 Thomas Jefferson University Extracto de celulas tumorales modificadas con hapteno y procedimientos para tratar cancer.
PL328790A1 (en) * 1996-10-04 1999-02-15 Univ Jefferson T-lymphocytes provoking an immunological response and methods of using them
AU2686999A (en) * 1998-02-17 1999-08-30 Thomas Jefferson University Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes

Also Published As

Publication number Publication date
WO1999052546A3 (en) 1999-12-16
CA2327339A1 (en) 1999-10-21
CN1301174A (zh) 2001-06-27
AU3482199A (en) 1999-11-01
EP1067960A2 (en) 2001-01-17
AR020067A1 (es) 2002-04-10
WO1999052546A2 (en) 1999-10-21
JP2003524583A (ja) 2003-08-19

Similar Documents

Publication Publication Date Title
GB2311314B (en) A method of installing the casing in a well and apparatus therefore
GB2380213B (en) Apparatus including a wellbore and wellbore casing
GB2389601B (en) Well-bore sensor apparatus and method
GB9511538D0 (en) Wellbore methods and apparatus
EG20651A (en) Method of creating a casing in a borehole
GB2352036B (en) Near wellbore modelling method and apparatus
GB2312909B (en) Wellbore methods and apparatus
EP0977536A4 (en) ACOUSTIC DEVICE FOR RESPIRATORY THERAPY
GB9502968D0 (en) Coalbed drilling
GB2291168B (en) Wellbore perforating methods and apparatus
HUP0003501A3 (en) Method for producing glufosinate and their intermediates
GB2320269B (en) Wellbore methods and apparatus
GB2338063B (en) Sensor apparatus and method
GB9515036D0 (en) Adjustable surface wellhead casing hanger
GB2307258A8 (en) Adjustable surface wellhead casing hanger
PL366240A1 (pl) Sposób indukowania reakcji przeciwnowotworowej przeciwko przerzutom płucnym u pacjentów z czerniakiem
PL335074A1 (en) Method of obtaining eprosartane
GB9708449D0 (en) Acoustic apparatus and method
IL138311A0 (en) A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
PL339188A1 (en) Method of obtaining oxaphosphorin-2-amines
PL334901A1 (en) Method of obtaining benzothiazolones
GB2338009B (en) A method of installing the casing in a well and apparatus therefor
GB2293652B (en) Methods of predicting mechanical failure in undergound formations
PL335887A1 (en) Method of obtaining arylaminotriazole pyridines
PL336266A1 (en) Method of obtaining epsilon-caprolactams